Sultosilic acid (piperazine salt)

Sultosilic acid piperazine salt (Piperazine sultosylate; A-585) is a lipid-lowering agent. Sultosilic acid piperazine salt modifies the blood lipids levels, reduces platelet adhesiveness without promoting peroxisomal activity of hepatocytes or producing other adverse side-effects[1].

Product Specifications

CAS Number

[57775-27-6]

Product Name Alternative

Piperazine sultosylate; A-585

UNSPSC

12352005

Target

Others

Type

Reference compound

Related Pathways

Others

Applications

Metabolism-sugar/lipid metabolism

Field of Research

Metabolic Disease

Assay Protocol

https://www.medchemexpress.com/sultosilic-acid-piperazine-salt.html

Purity

98.88

Solubility

DMSO : 250 mg/mL (ultrasonic)

Smiles

O=S(C1=CC(OS(=O)(C2=CC=C(C)C=C2)=O)=CC=C1O)(O)=O.N3CCNCC3

Molecular Formula

C17H22N2O7S2

Molecular Weight

430.50

References & Citations

[1]Vinazzer H, et al., Double-blind cross-over study of the effect of sultosilic acid piperazine salt (A-585) and bezafibrate in primary hyperlipoproteinemia. Atherosclerosis. 1983 Nov;49 (2) :109-18.